Target intelligence / Profile preview

Aurora kinase A and Aurora kinase B (Aurora A (AURKA) and Aurora B (AURKB))

Target
Aurora A (AURKA) and Aurora B (AURKB)
Molecular classification
Enzyme, Protein kinase, Serine/threonine kinase, Cell cycle regulator
01

Overview

Aurora kinase A and Aurora kinase B are closely related serine/threonine kinases that play pivotal roles in regulating the eukaryotic cell cycle, particularly during mitosis[2][4][9]. Aurora kinase A is required for entry into mitosis, centrosome maturation, and assembly of a functional mitotic spindle[1][4][5]. It localizes mainly to centrosomes and spindle poles, ensuring proper bipolar spindle formation and accurate chromosome segregation. Aurora kinase B, a key component of the chromosomal passenger complex (with proteins such as INCENP and Survivin), regulates chromatid cohesion, chromosome alignment, spindle assembly, and cytokinesis, and localizes to chromosomes and the central spindle during mitosis[5][7][9]. Both kinases are frequently overexpressed or hyperactivated in cancers, correlating with poor prognosis and making them attractive targets for small-molecule inhibitors in oncology drug development[2][4][9].

Other names
Aurora A: Serine/threonine-protein kinase 6, STK6, AIKAurora B: Serine/threonine-protein kinase 12, STK12, AIM-1Aur kinases
02

Mechanism of action

Inhibition of kinase activity at the ATP-binding site. Disruption of cell division leading to mitotic arrest and apoptosis. Antiproliferative effects on tumor cells[4][6].

03

Biological functions

Cell cycle regulationMitosisCentrosome maturation (Aurora A)Spindle assembly (Aurora A)Chromosome alignment and segregation (Aurora B)Cytokinesis (Aurora B)Genomic stabilityTumorigenesis
04

Disease associations

Cancer (oncogenic drivers in multiple tumor types)Genomic instability-related diseases
05

Safety considerations

Bone marrow suppression (neutropenia, thrombocytopenia)Gastrointestinal toxicityFatigueRisk of off-target effects due to similarity between Aurora kinases and other protein kinasesPotential for developing resistance[4]
06

Interacting drugs

Alisertib (MLN8237)

6 more in the full profile.

07

Biomarkers

Overexpression of Aurora A or B (immunohistochemistry or gene mutation) as a potential predictive or prognostic biomarker in several cancersPhosphorylation status of substrate proteins (e.g., Histone H3 phosphorylation by Aurora B)[2]

Beyond the preview

Go deeper on Aurora kinase A and Aurora kinase B (Aurora A (AURKA) and Aurora B (AURKB)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aurora kinase A and Aurora kinase B (Aurora A (AURKA) and Aurora B (AURKB)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call